“Fact Sheet: Addressing Addiction and the Overdose Epidemic,” The White House, March 1, 2022, available at <https://www.whitehouse.gov/briefing-room/statements-releases/2022/03/01/fact-sheet-addressing-addiction-and-the-overdose-epidemic/> (last visited February 27, 2024).+(last+visited+February+27,+2024).>Google Scholar

“SAMHSA Announces Unprecedented $30 Million Harm Reduction Grant Funding Opportunity to Help Address the Nation’s Substance Use and Overdose Epidemic,” SAMHSA, December 8, 2021, available at <https://www.samhsa.gov/newsroom/press-announcements/202112081000> (last visited February 27, 2024).+(last+visited+February+27,+2024).>Google Scholar

Consider, for example, the PIPES Act of 2022, introduced by Senators Marco Rubio and Joe Manchin, which would restrict the use of federal funds for syringe service programs and other drug paraphernalia. This legislation was introduced in response to the allegation that federal funding would be used on providing “crack pipes” to drug users. S.G. Stolberg, “Uproar Over ‘Crack Pipes’ Puts Biden Drug Strategy at Risk,” New York Times, February 21, 2022, available at <https://www.nytimes.com/2022/02/21/us/politics/biden-harm-reduction-crack-pipes.html> (last visited February 27, 2024).+(last+visited+February+27,+2024).>Google Scholar

Aspinall, E.J. et al., “Are Needle and Syringe Programmes Associated with a Reduction in HIV Transmission Among People Who Inject Drugs: A Systematic Review and Meta-Analysis,” International Journal of Epidemiology 43, no. 1 (2014): 235–248.Google ScholarPubMed

Hagan, H. et al., “Reduced Injection Frequency and Increased Entry and Retention in Drug Treatment Associated with Needle-Exchange Participation in Seattle Drug Injectors,” Journal of Substance Abuse Treatment 19, no. 3 (2000): 247–252.Google ScholarPubMed

Pinkham, S. and Malinowska-Sempruch, K., Women, Harm Reduction, and HIV (2007), at 3; S. A. Springer et al., “Drug Treatment as HIV Prevention Among Women and Girls Who Inject Drugs from a Global Perspective: Progress, Gaps, and Future Directions,” Journal of Acquired Immune Deficiencies Syndrome 69, no. 1 (2015): S155-161.Google Scholar

See Boyd, S.C., Mothers and Illicit Drugs: Transcending the Myths (University of Toronto Press, 1999).Google Scholar

Ait-Daoud, N. et al., “Women and Addiction: An Update,” Medical Clinics of North America 103, no 4 (2019): 699–711.Google ScholarPubMed

Id.; S. F. Greenfield et al., “Gender Differences in Alcohol Treatment: An Analysis of Outcome from the COMBINE Study,” Alcoholism: Clinical & Experimental Research 34, no. 10 (2010): 1803-1812.Google Scholar

Moran-Santa Maria, M. M. et al., “Ovarian Hormones and Drug Abuse,” Current Psychiatry Reports 16, no 11 (2014): 511–523, at 511; S. A. M. Bobzean et al., “Sex Differences in the Neurobiology of Drug Addiction,” Experimental Neurology 259, no. 1 (2014): 64-74.Google ScholarPubMed

“UN: AIDS Fight Depends on Respect for Rights,” Human Rights Watch, May 31, 2006, available at <http://hrw.org/english/docs/2006/06/01/global13496.htm> (last visited February 27, 2024); M. E. Epele, “Gender, Violence, and HIV: Women’s Survival in the Streets,” Culture, Medicine & Psychiatry 26, no. 1 (2002): 33-53.+(last+visited+February+27,+2024);+M.+E.+Epele,+“Gender,+Violence,+and+HIV:+Women’s+Survival+in+the+Streets,”+Culture,+Medicine+&+Psychiatry+26,+no.+1+(2002):+33-53.>Google Scholar

Pinkham and Malinowska-Sempruch, supra note 6, at 3.Google Scholar

“A History of the Drug War,” Drug Policy Alliance, available at <https://drugpolicy.org/issues/brief-history-drug-war> (last visited February 27, 2024).+(last+visited+February+27,+2024).>Google Scholar

Terplan, M. et al., “Women-Centered Drug Treatment Services and Need in the United States, 2002–2009,” American Journal of Public Health 105, no. 11 (2015): E50-E54, at E50.Google ScholarPubMed

Principles of Harm Reduction, National Harm Reduction Coalition, available at <https://harmreduction.org/about-us/principles-of-harm-reduction/> (last visited February 27, 2024).+(last+visited+February+27,+2024).>Google Scholar

Covington, S. S., “Women and Addiction: A Trauma-Informed Approach,” Journal of Psychoactive Drugs S5 (2008): 377–85, at 377.Google Scholar

Staff, Editorial, Alcohol and Drug Abuse Statistics, American Addiction Centers, June 10, 2022, available at <https://americanaddictioncenters.org/rehab-guide/addiction-statistics> (February 27, 2024).Google Scholar

“Social Determinants of Substance Use & Overdose Prevention,” Minnesota Department of Health, available at <https://www.health.state.mn.us/communities/opioids/prevention/socialdeterminants.html> (last visited February 27, 2024).+(last+visited+February+27,+2024).>Google Scholar

Auerbach, J. D. and Smith, L. R., “Theoretical Foundations of Research Focused on HIV Prevention Among Substance-involved Women: A Review of Observational and Intervention Studies,” Journal of Acquired Immune Deficiency Syndromes 69, no. Suppl. 2 (2015): S146–S154, at S146.Google ScholarPubMed

El-Bassel, N. et al., “Dual HIV Risk and Vulnerabilities Among Women Who Use or Inject Drugs: No Single Prevention Strategy is the Answer,” Current Opinions in HIV and AIDS 7, no. 4 (2012): 326–331, at 326.Google ScholarPubMed

Pinkham & Malinowska-Sempruch, supra note 6, at 6-7.Google Scholar

El-Bassel, N. and Strathdee, S. A., “Women Who Use or Inject Drugs: An Action Agenda for Women- Specific, Multilevel and Combination HIV Prevention and Research,” Journal of Acquired Immune Deficiency Syndromes 69, no. suppl. 2 (2015): S182–S190, at S187; Pinkham and Malinowska-Sempruch, supra note 6, at 6-7.Google ScholarPubMed

Cleghorn, E., “Medical Myths About Gender Roles Go Back to Ancient Greece. Women Are Still Paying the Price Today,” TIME, June 17, 2021, available at <https://time.com/6074224/gender-medicine-history/> (last visited February 27, 2024).+(last+visited+February+27,+2024).>Google Scholar

Broussard, C. S. et al., “Maternal Treatment with Opioid Analgesics and Risk for Birth Defects,” American Journal of Obstetrics and Gynecology 204, no. 4 (2011): E1-314, at E1.Google Scholar

T. Castillo, “Meet the Women Fighting for Gender Equality in Addiction Treatment,” Pacific Standard, June 3, 2019, available at <https://psmag.com/social-justice/meet-the-women-fighting-for-gender-equality-in-drug-treatment> (last visited February 27, 2024).+(last+visited+February+27,+2024).>Google Scholar

Id. Google Scholar

Boyd, supra note 7.Google Scholar

U.N. Office on Drugs and Crime, HIV/AIDS Prevention and Care for Female Injecting Drug Users (2006).Google Scholar

“Child Welfare: The Drug War Breaks Up Families,” Uprooting the Drug War, available at <https://uprootingthedrugwar.org/child-welfare/#content> (last visited February 27, 2024).+(last+visited+February+27,+2024).>Google Scholar

Id. Google Scholar

Trivedi, S., “The Harm of Child Removal,” New York University Review of Law & Social Change 43, no. 1 (2019): 523–80.Google Scholar

El-Bassel and Strathdee, supra note 22, at S187.Google Scholar

Pinkham and Malinowska-Sempruch, supra note 6, at 6-7.Google Scholar

Id. at 7.Google Scholar

“Data on Poverty Deepens for Women and Girls, According to Latest Projections,” U.N. Women, February 1, 2022, available at <https://data.unwomen.org/features/poverty-deepens-women-and-girls-according-latest-projections> (last visited February 27, 2024).+(last+visited+February+27,+2024).>Google Scholar

“Understanding the Relationship Between Poverty and Addiction,” St. Joseph Institute for Addiction, June 18, 2018, available at <https://stjosephinstitute.com/understanding-the-relationship-between-poverty-and-addiction/> (last visited February 27, 2024); U.N. Development Programme, Perspectives on the Development Dimensions of Drug Control Policy (2015).+(last+visited+February+27,+2024);+U.N.+Development+Programme,+Perspectives+on+the+Development+Dimensions+of+Drug+Control+Policy+(2015).>Google Scholar

Pinkham and Malinowska-Sempruch, supra note 6, at 25.Google Scholar

Pinkham, S. et al., “Developing Effective Health Interventions for Women Who Inject Drugs: Key Areas and Recommendations for Program Development and Policy,” Advances in Preventive Medicine 12, no. 1 (2012): 1–10, at 5.Google Scholar

Pinkham and Malinowska-Sempruch, supra note 6, at 10.Google Scholar

Id. Google Scholar

Id. Google Scholar

U.N. Women, A Gender Perspective on the Impact of Drug Use, the Drug Trade and Drug Control Regimes (July 2014).Google Scholar

Id. Google Scholar

R. Manjoo and U.N. Secretary-General, Pathways to, Conditions and Consequences of Incarceration Among Women, Rep. of the Special Rapporteur on Violence against Women, U.N. doc. no. A/68/340, (Aug. 21, 2013).Google Scholar

See, e.g., W. Va. Code § 9-3-6 (2021).Google Scholar

Ait-Daoud, N. et al., “Women and Addiction: An Update,” Medical Clinics of North America 103, no 4 (2019): 699–711, at 705.Google ScholarPubMed

Substance Abuse and Mental Health Services Administration, Substance Use Disorder Treatment for Persons with Co-Occurring Disorders 174 (2020).Google Scholar

Weinberger, A. H. et al., “Two Decades of Smoking Cessation Treatment Research on Smokers with Depression: 1990-2010,” Nicotine Tobacco Research 15, no. 6 (2013): 1014–31, at 1014.Google ScholarPubMed

Substance Abuse and Mental Health Services Administration, Addressing the Specific Needs of Women for Treatment of Substance Use Disorder (2021).Google Scholar

Keyser-Marcus, L. et al., “Trauma, Gender, and Mental Health Symptoms in Individuals with Substance Use Disorders,” Journal of Interpersonal Violence 30, no. 1 (2015): 3–24, at 3.Google ScholarPubMed

El-Bassel and Strathdee, supra note 22, at S187.Google Scholar

Pinkham and Malinowska-Sempruch, supra note 6, at 9.Google Scholar

El-Bassel and Strathdee, supra note 22, at S187.Google Scholar

Covington, S. S. et al., “Evaluation of a Trauma-Informed and Gender-Responsive Intervention for Women in Drug Treatment,” Journal of Psychoactive Drugs 40, suppl. 5 (2008): 387–98.Google Scholar

Pinkham and Malinowska-Sempruch, supra note 6, at 14.Google Scholar

Id. Google Scholar

Id. Google Scholar

Id. Google Scholar

Shirley-Beavan, S. et al., “Women and Barriers to Harm Reduction Services: A Literature Review and Initial Findings from a Qualitative Study in Barcelona, Spain,” Harm Reduction Journal 17, no. 1 (2020): 78–91, at 82.Google ScholarPubMed

Id. Google Scholar

Malinowska-Sempruch, K. and Rychkov, O., The Impact of Drug Policy on Women 16 (2015).Google Scholar

Manjoo, R., Multiple and Intersecting Forms of Discrimination and Violence against Women, Rep. of the Special Rapporteur on Violence against Women, U.N. doc.no. A/HRC/17/26, at 11 (2011).Google Scholar

National Harm Reduction Coalition, supra note 15.Google Scholar

See, e.g., D. E. Logan and Marlatt, G. A., “Harm Reduction Therapy: A Practice-Friendly Review of Research,” Journal of Clinical Psychology 66, no. 2 (2010): 201–14, at 201; T. Rhodes and D. Hedrich, eds., Harm Reduction: Evidence, Impacts, and Challenges (2010): at 115-63.Google Scholar

Sander, G. et al., “The Global State of Harm Reduction in Prisons,” Journal of Correctional Health Care 25, no. 2 (2019): 105–20, at 105.Google ScholarPubMed

See, e.g., HIPS, available at <https://www.hips.org/> (last visited March 25, 2022) (a harm reduction program based in Washington, D.C., serving sex workers).+(last+visited+March+25,+2022)+(a+harm+reduction+program+based+in+Washington,+D.C.,+serving+sex+workers).>Google Scholar

Ettorre, E., “Revisioning women and Drug Use: Gender Sensitivity, Embodiment and Reducing Harm,” International Journal of Drug Policy 15, no 5-6 (2004): 327–35, at 329.Google Scholar

Nowogrodzki, A., “Inequality in Medicine,” Nature 550, no. 1 (2017): S18–S19.Google ScholarPubMed

Despite the relative prevalence of reproductive and sexual health services for women in harm reduction spaces, women who use drugs are still twice as likely to experience unintended pregnancies and are significantly less likely to be using contraceptives. L. Owens et al., “Providing Reproductive Health Services for Women Who Inject Drugs: A Pilot Program,” Harm Reduction Journal 17, no. 1 (2020) 47-58, at 47; M. Terplan et al., “Contraceptive Use and Method Choice Among Women with Opioid and Other Substance Use Disorders: A Systematic Review,” Preventive Medicine 80, no. 1 (2015): 23-31, at 23.Google Scholar

Owens et al., supra note 69.Google Scholar

Pinkham et al., supra note 38, at 6.Google Scholar

Id. Google Scholar

Id. Google Scholar

. Id. While these resources are helpful in identifying programming that helps women, there remains a dearth of scholarship studying the impacts of harm reduction programming that focuses on men’s drug use or gender neutrality. Researchers should seek more evidence on these issues in order to determine how best to serve women who use drugs in harm reduction spheres.Google Scholar

Id. Google Scholar

Id. Google Scholar

Id. Google Scholar

Harm Reduction International, Women and Harm Reduction 1 (2018).Google Scholar

Collins, A. B. et al., “Gender and the Overdose Crisis in North America: Moving Past Gender-Neutral Approaches in the Public Health Response,” International Journal of Drug Policy 69, no. 1 (2019): 43–45, at 44.Google ScholarPubMed